This fund is currently closed to new and renewal applications due to lack of sufficient funding. CPR allocates funding to all patient’s that are approved for a grant so that it is available when needed by the patient. Therefore, during the period that a fund is closed to new applications, CPR continues to provide support to all patients in those funds that have an active award. Funds reopen often so please continue to visit our Disease Fund page to check the status of the fund.
Co-Pay Relief Program Fund Notices
Would you like to be notified when any new funds open, or when any of our current funds re-open? If so, please sign up using the “Get Notified” link below. As a member of our subscriber community you will receive important news about all of our disease funds, so join today!
Co-pay, Co-Insurance & DeductibleMaximum Award Level
$3,500 Per Year
- Household Income Requirements 300% or less of Federal Poverty Guideline (FPG) (adjusted for Cost of Living Index (COLI) and number in household)
- Insurance Requirements Medicare, Medicaid, or Military Benefits
- Must reside and receive treatment in the United States.
Lupus is a chronic inflammatory disease that occurs when the body’s immune system creates autoantibodies that attack and destroy healthy cells and tissues. These autoantibodies cause inflammation, pain and damage in various tissues and organs. Lupus can affect many different body systems – including the joints, skin, kidneys, blood cells, brain, heart and lungs. Lupus is a disease of flares (symptoms worsen) and remissions (symptoms improve). The most distinctive sign of lupus- a facial rash that resembles the wings of a butterfly unfolding across both cheeks – occurs in many but not all cases of lupus. Lupus occurs most frequently between the ages of 15 – 44, more common in women, and women of color are two to three times more likely to develop lupus than Caucasians. There are many types of lupus – systemic lupus erythematosus (most common), discoid lupus erythematosus, subacute cutaneous lupus erythematosus, drug-induced lupus and neonatal lupus.